Risk Factors for the First Episode of Klebsiella pneumoniae Resistant to Carbapenems Infection in Critically Ill Patients: A Prospective Study
Table 1
Baseline characteristics of participants.
KPRC ()
Non-MDR bacterial infection ()
No bacteria group ()
Sex (male)
14 (56)
0.328
8 (44.4)
0.199
26 (66.7)
0.436
Age (years)
62 (50, 69)
0.150
47 (32, 62)
0.229
62 (40, 76)
0.245
Medical patients
14 (56)
0.597
8 (44)
0.223
17 (43.6)
0.443
Diagnosis during admission
Sepsis
3 (12)
0.590
3 (17)
0.683
3 (8)
0.671
Neurological disease
4 (16)
0.201
1 (5)
0.127
6 (15)
1.0
Pancreatitis
2 (8)
0.223
0 (0)
1.0
0 (0)
0.149
ARDS
4 (16)
0.277
1 (6)
0.380
2 (5)
0.199
Neurosurgical disease
5 (20)
0.587
4 (22)
1.0
12 (31)
0.397
Abdominal surgery
3 (12)
0.773
1 (5)
0.628
4 (10)
1.0
Trauma patients
2 (8)
0.656
3 (17)
0.634
4 (10)
1.0
Other
2 (8)
0.225
5 (28)
0.110
8 (21)
0.292
APACHE II score
15 (12, 20)
0.204
13 (10, 19)
0.886
15 (10, 18)
0.230
SOFA score
7 (4, 8)
0.768
7 (6, 9)
1.0
7 (5, 9)
1.0
Hospitalization in the last 3 months
6 (24)
0.157
1 (5.6)
0.209
4 (10.3)
0.170
Admission from emergency department
15 (60)
0.355
7 (38.9)
0.223
18 (46.2)
0.315
Diabetes mellitus
5 (20.8)
0.156
2 (11.1)
0.679
2 (5.1)
0.095
Chronic lung disease
2 (8.3)
0.665
3 (16.7)
0.636
6 (15.4)
0.699
Chronic heart disease
7 (29.2)
0.570
4 (22.2)
0.731
14 (35.9)
0.784
Chronic renal failure
2 (8.3)
0.320
0 (0)
0.498
1 (2.6)
0.552
Neurological disease
9 (37.5)
0.108
4 (22.2)
0.333
20 (51.3)
0.311
Chronic liver disease
2 (8.3)
0.585
1 (5.6)
1.0
1 (92.6)
0.552
Malignancy
2 (8.3)
0.401
2 (11.1)
1.0
1 (2.6)
0.552
Immunodeficiency
2 (8.3)
0.940
1 (5.6)
1.0
3 (7.7)
1.0
Data are presented as median (25% and 75% quartiles) or (%); KPRC: Klebsiella pneumonia resistant to carbapenems; MDR: multidrug resistant bacteria; APACHE: Acute Physiology and Chronic Health Evaluation; SOFA: Sequential Organ Failure Assessment; ARDS: Acute respiratory distress syndrome; : comparison between three groups; : KPRC versus non-MDR group, KPRC versus no bacteria group. Results are by univariate analysis.
